UPDATE – Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference Feb 25, 2025 10:15AM
Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference Feb 25, 2025 07:00AM
TD Cowen Downgrades Spero Therapeutics (SPRO) to Hold Nov 18, 2024 02:44AM
TD Cowen Upgrades Spero Therapeutics (SPRO) to Buy Aug 6, 2024 07:22AM
Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference Feb 26, 2024 08:05AM


Feb 28, 2023 08:05AM Spero Therapeutics to Present at Upcoming Investor Conferences
Jun 28, 2022 05:54AM Expect Spero Therapeutics (SPRO) to Seek Partnership for tebipenem - Cowen Reiterates Market Perform on Stock
May 4, 2022 05:33AM UPDATE: Cowen Downgrades Spero Therapeutics (SPRO) to Market Perform
Feb 25, 2021 08:30AM Spero Therapeutics to Present at Investor Conferences in March
Sep 11, 2020 06:55AM Spero Therapeutics (SPRO) Announces Pricing of Common Stock and Series D Convertible Preferred Stock
Sep 11, 2020 06:54AM Spero Therapeutics Announces Pricing of Securities Offering
Sep 11, 2020 06:54AM Spero Therapeutics Announces Pricing of Securities Offering
Sep 9, 2020 04:34PM Spero Therapeutics (SPRO) Announces Proposed 8M Share Common Offering
Sep 9, 2020 04:33PM Spero Therapeutics Announces Proposed Public Offering
Sep 9, 2020 04:33PM Spero Therapeutics Announces Proposed Public Offering
Feb 26, 2020 04:00PM Spero Therapeutics to Present at March Investor Conferences
Feb 26, 2020 04:00PM Spero Therapeutics to Present at March Investor Conferences
Mar 1, 2019 08:30AM Spero Therapeutics to Present at March Investor Conferences
Jul 13, 2018 05:47AM Spero Therapeutics (SPRO) Prices 3.78M Share Offering at $12.50/Sh
Jul 12, 2018 08:10PM Spero Therapeutics Announces Pricing of Securities Offering
Jul 9, 2018 04:11PM Spero Therapeutics (SPRO) Commences 4.5M Common Stock Offering
Jul 9, 2018 04:10PM Spero Therapeutics Announces Proposed Offering of Common Stock
Mar 1, 2018 08:00AM Spero Therapeutics to Present at March Investor Conferences
Nov 27, 2017 05:38AM Cowen Starts Spero Therapeutics (SPRO) at Outperform
Nov 13, 2017 07:00AM Spero Therapeutics Announces Underwriters’ Option Exercise
Nov 6, 2017 04:01PM Spero Therapeutics Announces Closing of Initial Public Offering
Nov 2, 2017 05:42AM Spero Therapeutics Inc. (SPRO) Prices 5.5M Share IPO at $14/Sh
Nov 1, 2017 06:00PM Spero Therapeutics Announces Pricing of Initial Public Offering